Windsor, Alberta 10/20/2009 11:02:45 PM
News / Business

Amgen and Pfizer to Present Scientific Data on Enbrel at 2009 American College of Rheumatology Scientific Meeting

Amgen (NASDAQ: AMGB) and Pfizer (NYSE: PFE) have announced scientific data about ENBREL. The data is being presented from October 17-21, 2009 in Philadelphia, Pa. at the 2009 American College of Rheumatology Scientific Meeting. The data that is being presented has been generated through 17 years of collective clinical experience. The studies include a range of patients with moderate to severe rheumatoid arthritis and psoriatic arthritis.

 

Free Hot Penny Stocks, an online financial publication, provides investors timely stock market alerts. Free hot penny stocks profiles stock picks that could generate higher returns than average. These penny stocks include stocks with news, chart breakouts or increased volume.

Sign Up Today for our Penny Stock Newsletter

 

Below are some abstracts of interest on ENBREL data:

 

·         Sustainability of Clinical Remission with Etanercept and Methotrexate, in Combination or as Monotherapy, in Early Active Rheumatoid Arthritis Lead author:  Emery, P. Abstract No. 1656 (Tuesday, Oct. 20, 2009)

 

·         Etanercept Benefits Skin, Joint, and Entheseal Symptoms in Patients with Psoriasis and Psoriatic Arthritis: The PRESTA Trial Lead author:  Kirkham, B. Abstract No. 523 (Sunday, Oct. 18, 2009)

 

·         Safety Profiles of Disease-Modifying Anti-Rheumatic Drugs and Biologics in Patients with Rheumatoid Arthritis:  Observations from the RADIUS Registry Lead author:  Gibofsky, A. Abstract No. 1593 (Sunday, Oct. 18, 2009)

 

·         Identifying Clinical Features of Disseminated Histoplasmosis in Patients Receiving TNF Inhibitors Lead author:  McCroskery, P.  Abstract No. 999 (Monday, Oct. 19, 2009)

 

Source: Amgen

 

About Amgen and Pfizer

Amgen and Pfizer market ENBREL in North America. Pfizer markets ENBREL outside of North America. Immunex Corporation, a wholly owned subsidiary of Amgen, manufactures ENBREL.

 

Sign Up for Free Hot Penny Stocks’ FREE Penny Stock Newsletter.

 

About Us

 

Free Hot Penny Stocks is a financial website and independent electronic publication that provides information and free penny stock alerts on selected publicly traded companies. We also track small cap companies and other stocks that may be positioned to break out. These penny stocks might have news, increased volume or chart breakouts. These penny stocks that are alerted could generate greater than average returns. Feel free to visit our penny stock forum to discuss other penny stock picks or penny stocks that you might own.

 

Free Hot Penny Stocks is not a registered investment advisor or broker-dealer. Please do your own Due Diligence before investing in any of the stocks mentioned above. To feature a company on our web site please contact us at the email listed below.

 

Please click here to read the full disclaimer